Announcements Trials
Browse Landscape

Phase

Phase 2 40Phase 3 19Phase NA 8Phase 2/3 5Phase 1/2 3Phase 1 3Phase 4 2

Status

Unknown 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 4Gastrointestinal 3Thoracic 2Other solid neoplasm 1Gynecologic 1

Conditions

Rectal Neoplasms 2Pancreatic Neoplasms 1

Interventions

Gemcitabine 218Fluorouracil 142Oxaliplatin 132Capecitabine 122pembrolizumab 113Irinotecan 110Leucovorin 104Bevacizumab 98Nivolumab 80Cisplatin 80130-nm albumin-bound paclitaxel 80Cetuximab 79Radiotherapy 78Albumin-Bound Paclitaxel 59Sorafenib 56Paclitaxel 53Cyclophosphamide 50Carboplatin 47Magnetic Resonance Spectroscopy 44Specimen Handling 39Docetaxel 37Taxes 36fludarabine 34Radiation 34durvalumab 33Ipilimumab 33Erlotinib Hydrochloride 33Biopsy 33Radiosurgery 27Folfox protocol 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Chemoradiotherapy × Gastrointestinal × Clear all
NCT05417386 2025-11-18

FOLFIRINOX + NIS793 in Pancreatic Cancer

Massachusetts General Hospital

Phase 1 Terminated
4 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06300489 2024-03-08

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Zhejiang Cancer Hospital

Phase 1 Unknown
30 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02277158 2014-12-02

Phase I Study of CCRT as Adjuvant Treatment for Stage II/III Operable Rectal Cancer.

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase 1 Unknown
18 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡